Evidence map›Paper›PMID 21986944›Full record

ArticleOncogene2012

Male germ cell-associated kinase is overexpressed in prostate cancer cells and causes mitotic defects via deregulation of APC/CCDH1.

L-Y Wang, H-J Kung

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. CMGC Kinases in Viral Infection and Human Disease.Pathogens (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

L-Y WangDepartment of Biochemistry and Molecular Medicine and University of California Davis Cancer Center, School of Medicine, University of California at Davis, Sacramento, CA, USA.
H-J Kung
University of California, Davis · US

Funding

TYROSINE KINASES AND PROSTATE GROWTHR01DK052659 · NIDDK · UNIVERSITY OF CALIFORNIA DAVIS · PI KUNG, HSING-JIEN · 1997 to 2011
$2.9M
Androgen Signaling and Coactivator Regulation in PCAR01CA150197 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KUNG, HSING-JIEN · 2010 to 2014
$1.7M
Modeling androgen receptor in prostate cellsR01DK078243 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KUNG, HSING-JIEN · 2007 to 2010
$1.2M
NCI NIH HHS CA150197NCI NIH HHS R01 CA150197NIDDK NIH HHS DK078243NIDDK NIH HHS DK526529NIDDK NIH HHS R01 DK052659NIDDK NIH HHS R01 DK078243
6 · The paper itself

Abstract

Male germ cell-associated kinase (MAK), a direct transcriptional target of androgen receptor (AR), is a co-activator of AR. In this study, we determined the activating mechanism of MAK and identified a previously unknown AR-independent role of MAK in mitosis. We found that MAK kinase activity requires dual phosphorylation of the conserved TDY motif and that the phosphorylation is dynamic during cell cycle. MAK associates with CDH1 (FZR1, fizzy/cell division cycle 20 related 1) and phosphorylates CDH1 at sites phosphorylated by cyclin-dependent kinases. When MAK is overexpressed, the binding of CDH1 to anaphase promoting complex/cyclosome decreased, resulting in an attenuation of anaphase-promoting complex/C ubiquitin ligase activity and the consequential stabilization of the CDH1 targets such as Aurora kinase A and Polo-like kinase 1. As such, overexpression of MAK leads to mitotic defects such as centrosome amplification and lagging chromosomes. Our immunohistochemistry result showed that MAK is overexpressed in prostate tumor tissues, suggesting a role of MAK in prostate carcinogenesis. Taken with our previous results, our data implicate MAK in both AR activation and chromosomal instability, acting in both early and late prostate cancer development.

Indexed as

Chromosomal InstabilityMitosisAmino Acid MotifsAnaphase-Promoting Complex-CyclosomeAurora Kinase AAurora KinasesCdh1 ProteinsCell Cycle ProteinsCell Line, TumorCell Transformation, NeoplasticCyclin-Dependent KinasesDown-RegulationHumansImmunohistochemistryMalePhosphorylationAnaphase-Promoting Complex-CyclosomeAURKA protein, humanAurora Kinase AAurora KinasesCdh1 ProteinsCell Cycle ProteinsCyclin-Dependent KinasesFZR1 protein, humanMAK protein, humanPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsReceptors, AndrogenUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligases

Identifiers

PMID21986944
PMCPMC3566783
OpenAlexW1976564348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.